Literature DB >> 4864269

Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies.

J C Niederman, R W McCollum, G Henle, W Henle.   

Abstract

Mesh:

Year:  1968        PMID: 4864269     DOI: 10.1001/jama.203.3.205

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  75 in total

1.  The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.

Authors:  E R Leight; B Sugden; E R Light
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines.

Authors:  T Nilsson; H Zetterberg; Y C Wang; L Rymo
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors:  Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  The Pathogenic Role of the EB Virus.

Authors:  T Merigan
Journal:  Calif Med       Date:  1970-02

Review 5.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV.

Authors:  Wei Bu; Gregory M Hayes; Hui Liu; Lorraine Gemmell; David O Schmeling; Pierce Radecki; Fiona Aguilar; Peter D Burbelo; Jennifer Woo; Henry H Balfour; Jeffrey I Cohen
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

7.  Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus.

Authors:  M Dolyniuk; R Pritchett; E Kieff
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

8.  Antibodies to Epstein-Barr virus in patients with cryptococcosis.

Authors:  P H Levine; R D Diamond; J I Reisher
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

9.  Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.

Authors:  P R Band; P H Levine; V C Patwardhan; T K Shnitka; H F Pabst
Journal:  Can Med Assoc J       Date:  1973-01-20       Impact factor: 8.262

10.  Epstein-Barr virus. Heterophile responses in squirrel monkeys inoculated with virus-transformed autologous leukocytes.

Authors:  T Shope; G Miller
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.